LI-YUAN YU-LEE to Cell Line, Tumor
This is a "connection" page, showing publications LI-YUAN YU-LEE has written about Cell Line, Tumor.
Connection Strength
0.551
-
Bone secreted factors induce cellular quiescence in prostate cancer cells. Sci Rep. 2019 12 09; 9(1):18635.
Score: 0.089
-
Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGF?RIII-p38MAPK-pS249/T252RB Pathway. Cancer Res. 2018 06 01; 78(11):2911-2924.
Score: 0.079
-
Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 2013 Jun 13; 32(24):2973-83.
Score: 0.053
-
Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells. FASEB J. 2012 Oct; 26(10):4057-67.
Score: 0.053
-
Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein. Oncogene. 2004 Apr 01; 23(14):2499-506.
Score: 0.030
-
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. Oncogene. 2022 Feb; 41(6):757-769.
Score: 0.025
-
Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone. Oncogene. 2021 Jul; 40(27):4592-4603.
Score: 0.025
-
Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II. Cancer Res. 2018 05 15; 78(10):2490-2502.
Score: 0.020
-
BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia. 2018 01; 20(1):32-43.
Score: 0.019
-
Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. Oncotarget. 2017 Feb 07; 8(6):10145-10160.
Score: 0.018
-
Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res. 2015 Nov 15; 75(22):4949-59.
Score: 0.017
-
Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells. J Cell Sci. 2015 Dec 15; 128(24):4629-41.
Score: 0.017
-
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Mol Cell Proteomics. 2015 Mar; 14(3):471-83.
Score: 0.016
-
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. Cell Rep. 2014 Nov 20; 9(4):1318-32.
Score: 0.016
-
RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival. Mol Cancer Res. 2015 Feb; 13(2):348-57.
Score: 0.015
-
Targeting constitutively activated ?1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013 Apr; 11(4):405-17.
Score: 0.014
-
BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res. 2011 Aug 01; 71(15):5194-203.
Score: 0.012
-
A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 04; 27(39):5195-203.
Score: 0.010
-
A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res. 2007 Jul 15; 67(14):6544-8.
Score: 0.009
-
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004 May 01; 64(9):3072-8.
Score: 0.008
-
Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr Purif. 2003 Apr; 28(2):252-8.
Score: 0.007